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Abstract 
Traditional max2OV  criteria are typically based on attainment of a 2OV
  plateau, and 
threshold values for the respiratory exchange ratio, heart rate and blood lactate 
concentration. Despite long-standing criticisms directed at these criteria, their use 
remains widespread. This article discusses an alternative procedure, termed the 
verification phase, for confirming the attainment of true max2OV . Following a 
continuous incremental exercise test to the limit of tolerance and appropriate recovery 
period, the verification phase is performed and is characterised by a supramaximal 
square wave exercise bout. Consistent peak 2OV  values in the incremental and 
verification phases, confirms that a true max2OV  has been attained. Six recent studies 
investigated the utility of the verification phase for evaluating true max2OV . These 
studies consistently found small insignificant mean differences between the maximal 
2OV  attained in the incremental and verification phases. However, this group mean 
approach does not identify individual subjects who may not have attained a true 
max2OV . Notably, only one of the six studies reported a criterion threshold to verify 
the max2OV  of individual subjects. Further research is required to investigate the 
utility of different verification phase procedures and to establish a suitable verification 
criterion threshold for confirming true max2OV . 
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INTRODUCTION 
The maximal oxygen uptake ( max2OV ) has long been regarded as the gold standard 
measure of cardiorespiratory fitness (ATS/ACCP, 2003; Shephard et al., 1968) and its 
determination has become one of the most widely used test procedures in exercise 
physiology laboratories (Howley et al., 1995). The seminal work of Hill, Lupton, and 
Long (1924; 1923) introduced the max2OV  concept; however, many issues relating to 
the most appropriate test procedures for its determination remain unresolved. 
The attainment of max2OV  typically requires subjects to continue an incremental 
exercise test until they reach their limit of tolerance (Wagner, 2000). A problem arises 
in identifying those subjects who terminate the test prematurely and, therefore, may 
not have elicited a true max2OV . Taylor et al. (1955) stated that “the safest procedure 
is to insist on proof of the attainment of maximal oxygen intake in all cases." In 
pursuit of this ‘proof’ objective criteria have been proposed (see Howley et al., 1995, 
for review). Many investigators, however, have expressed concerns regarding the 
validity of these criteria (Cumming and Borysyk, 1972; Donnelly et al., 1990; 
Midgley et al., 2007; Niemela et al., 1980; Poole et al., 2007; Stachenfeld et al., 1992; 
Wyndham et al., 1959). 
Despite the long-standing criticisms directed at the currently used max2OV  criteria, as 
far as we are aware, until recently, there had been no attempt to identify new criteria. 
A number of experimental studies published in the last two years have investigated 
the utility of a procedure termed the ‘verification phase’ for establishing a true 
max2OV  (Foster et al., 2007; Hawkins et al., 2007; Midgley et al., 2006; Poole et al., 
2007; Rossiter et al., 2006). Following a continuous incremental exercise test to the 
limit of tolerance and an appropriate recovery period, the verification phase is 
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performed and is characterised by a supramaximal square wave bout of exercise to 
exhaustion (Figure 1)(where ‘supramaximal’ is defined as a workload higher than the 
last completed stage of an incremental max2OV  test). Consistent peak 2OV  values in 
the incremental and verification phases provide support for the view that a true 
max2OV  has been attained. A max2OV  test incorporating an incremental phase and 
appended verification phase, is conceptually similar to the discontinuous max2OV  
tests most commonly used from the 1920’s to the 1960’s, but with the notable 
advantage of requiring only one visit to the laboratory. Furthermore, research 
published during the last five years investigating the physiological limitations to 
max2OV , derived using incremental and constant load exercise protocols, have 
supported the conceptual basis for the verification phase procedure. The main purpose 
of this article was to discuss current knowledge regarding the verification phase and 
provide directions for future research. 
MECHANISTIC BASES FOR max2OV  
Early researchers concluded that 2OV  was limited by the rate of oxygen delivery and 
utilisation (defined by the maximal cardiac output and the maximal arteriovenous 
oxygen difference), despite an increased workload and oxygen demand. Using 
invasive measures, Mitchell et al. (1958) reported data on six male subjects whose 
oxygen uptake levelled off or actually declined at work rates beyond which elicited 
max2OV  and was coincident with a decline in cardiac output. The authors concluded 
that max2OV  is a measure of cardiac capacity and the ability to increase the 
arteriovenous oxygen difference, as opposed to the ability of the vascular bed to 
accommodate left ventricular output. The limitations to oxygen delivery and 
utilisation were, in turn, associated with an accumulation of the metabolites of 
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anaerobic metabolism causing exercise to be terminated. This has been termed the 
cardiovascular/anaerobic/catastrophic model of the limitation to max2OV  (Noakes, 
2008). 
Unresolved debates continue on whether central cardiorespiratory or local muscle 
circulatory and metabolic factors (or both) limit max2OV  (Howley et al., 1995). A 
recent series of experimental studies from the Copenhagen Muscle Research Centre 
have measured cardiac output and other components of the Fick principle during both 
incremental and constant load cycling to the limit of tolerance. These studies have 
corroborated the ‘classical’ interpretation of max2OV  and refined some aspects of our 
current understanding of this topic (Gonzalez-Alonso and Calbet, 2003; Mortensen et 
al., 2008; Mortensen et al., 2005). 
Gonzalez-Alonso and Calbet (2003) measured directly systemic haemodynamic and 
peripheral factors during constant load high-intensity cycling under conditions of heat 
stress and no heat stress. During both environmental conditions, cardiac output, mean 
arterial pressure, leg blood flow, and systemic oxygen delivery declined significantly 
at peak exercise, whereas arterial oxygen content and leg vascular resistance were 
maintained. The impaired systemic aerobic capacity that preceded the limit of 
exercise tolerance in both conditions was considered to be related to the diminished 
cardiac output and oxygen delivery to locomotive muscle. 
A series of further investigations (Mortensen et al., 2008; Mortensen et al., 2005) 
evaluated the contribution of the oxygen transport system to max2OV  in trained 
subjects during both incremental and constant load cycling to the limit of tolerance. 
Mortensen et al. (2005) reported that during incremental cycling, whole body 2OV  
increased linearly with workload, with max2OV  attained during the last 30 s of the 
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test protocol. Cardiac output and systemic oxygen delivery were shown to increase 
linearly up to 80% of peak power output and thereafter plateaued in conjunction with 
a decline in stroke volume and increased central venous and arterial pressures. In the 
constant load cycling at 85% of peak power output, max2OV  and peak cardiac output 
tended to be attained within 3 to 6 min, maintained for approximately 2 min, and 
declined before the termination of exercise. Systemic oxygen delivery reached peak 
values in 3-5 min but also declined before exercise termination. During both cycling 
conditions, systemic arteriovenous oxygen difference and oxygen extraction increased 
until the point of exercise termination. The similar 2OV  and cardiac output responses 
during the maximal and supramaximal cycling suggest that blood perfusion to active 
muscles might be limited during high-intensity whole-body exercise. 
Mortensen et al. (2008) subsequently examined the regulatory limits of systemic 
blood perfusion in exercising humans during constant load supramaximal cycling 
(110% of peak power output) compared with incremental cycling to the limit of 
tolerance. Incremental protocols involved increases in work rate every 1.5 min to 
elicit 25%, 50%, 75%, 90% and 100% of peak power output. Supramaximal 
workloads were imposed during the first 20 s of exercise to elicit 110% of peak power 
output. During supramaximal cycling, cardiac output, leg blood flow, and systemic 
and leg oxygen delivery reached peak values after 60–90 s and thereafter plateaued at 
values similar to or approximately 6% below that achieved at peak power output in 
the incremental test, while upper body blood flow remained unchanged. Cardiac 
output reached similar peak values in both cycling protocols, but was lower during 
supramaximal constant-load cycling at the point of exercise termination. 
Consequently, at exhaustion, systemic 2OV  was lower despite systemic oxygen 
extraction reaching similar values. Leg blood flow and leg oxygen delivery reached 
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similar values in the exercising limbs, however, leg 2OV  was lower compared to 
incremental cycling because of a reduced arteriovenous oxygen difference in the legs. 
These observations indicate that the limits of cardiac function and muscle 
vasoconstriction underlie the inability of the circulatory system to meet the increasing 
oxygen demand of skeletal muscles and other tissues during whole-body incremental 
exercise and constant load exercise in the severe exercise domain, when continued to 
the limit of tolerance.  
ARE CURRENTLY USED max2OV
  CRITERIA VALID? 
Taylor et al. (1955) observed that in response to multiple discrete bouts of exercise, 
each with a higher workload than the previous bout, an upper limit of oxygen uptake 
per unit of time was reached, despite subjects typically being able to exercise at even 
higher workloads. Ordinarily, the point at which the oxygen uptake curve (plotted 
against workload) ceased to rise was taken as max2OV . In most cases, when the 
workload was increased beyond that eliciting maximal oxygen uptake, the 2OV  
either remained unchanged or declined. In some cases, however, a slight rise was 
observed, necessitating the formulation of a strict objective criterion for identifying a 
true max2OV . The rationale for the now ubiquitous ‘ 2OV  plateau’ criterion (Midgley 
et al., 2007) proposed by Taylor et al. (1955), was that if 2OV  increased by no more 
than half of the mean increase in 2OV  (299.3 mL·min-1 for an average of 30 
measurements taken from 13 subjects at two or more grades below the grades 
resulting in the 2OV  plateau), then this was sufficient evidence that a maximal, or 
near maximal 2OV  had been reached. Various 2OV  plateau criteria methodologies 
have since been applied to a variety of exercise tests, including discontinuous, 
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incremental step and ramp protocols (Astorino et al., 2005; Mitchell et al., 1958; 
Poole et al., 2007). The 2OV  responses to these tests, however, have not consistently 
demonstrated plateau-like behaviour at the limit of tolerance despite apparent 
maximum effort. In fact, in contrast, Day et al. (2003) reported that 19 of 71 subjects 
in their study demonstrated an accelerated 2OV
  response as they approached fatigue 
during the end of an incremental exercise test. Incidence of the 2OV  plateau reported 
by previous studies has ranged from 0 to 100% (Astorino et al., 2005; Duncan et al., 
1997; Froelicher et al., 1974; Rossiter et al., 2006). Much of this inconsistency can be 
attributed to differences in the stringency of the 2OV
  plateau criterion, although the 
incidence of the 2OV  plateau has been suggested also to be largely dependent on the 
population under investigation, characteristics of the test protocol, and the 2OV  
sampling duration or data averaging method (Astorino et al., 2005; Rivera-Brown and 
Frontera, 1998). These factors considerably reduce the utility of the 2OV  plateau as a 
robust method for identifying a true max2OV  during a continuous ramp or 
incremental step test. However, it should be pointed out that the 2OV  plateau concept 
is intuitively robust and that the apparent limitations are not related to the concept 
itself, but to the inconsistent and often ill-conceived methodology that have been used 
to define it. The fact that the 2OV  plateau is not always evident also does not provide 
evidence against its existence (Wagner, 2000). 
A lack of motivation and effort may also explain the absence of a 2OV  plateau, since 
a relatively high level of anaerobiosis and discomfort are necessary to achieve a 
plateau (Wyndham et al., 1959). The absence of a 2OV  plateau, however, does not 
necessarily suggest that a maximum effort has not been given or that a true max2OV  
was not elicited. Studies have found no difference between the maximal heart rates, 
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respiratory exchange ratios, or post-exercise blood lactate concentrations among 
subjects who demonstrated a 2OV  plateau compared to those who did not (Astrand, 
1952; Rivera-Brown and Frontera, 1998; Rowland and Cunningham, 1992). Probably 
the most compelling piece of evidence highlighting the limitations of the 2OV  
plateau is that subjects who perform two identical continuous incremental step tests 
can demonstrate a 2OV  plateau in only one of the tests, despite negligible differences 
in max2OV  during the two tests (Katch et al., 1982; Midgley et al., 2006; Misquita et 
al., 2001). This situation appears paradoxical to the well established 
cardiovascular/anaerobic/catastrophic model (Noakes, 2008) and suggests that 
max2OV  is limited by some other mechanism, or at least, alternative mechanisms 
sometimes limit max2OV . Finally, an important point to consider in any critique of 
the 2OV  plateau, recently highlighted by Rossiter et al (2006), is that in the classical 
reports of Taylor et al. (1955) and Mitchell et al. (1958), there is no stated or implicit 
requirement for 2OV  to plateau during a particular
 bout of exercise: only that during 
another discrete time the maximal 2OV  value
 attained is not, or is only minimally 
higher, despite a higher workload. The definition of the 2OV  plateau proposed by 
these early researchers is not therefore directly applicable to the contemporary 
approach for max2OV  determination, which invariably involves continuous ramp or 
incremental step protocols. 
The lack of robustness of the 2OV  plateau highlights the need for secondary criteria 
to establish whether a maximal effort has been given. If a maximum effort has been 
given, it is assumed that max2OV  has been attained, irrespective of the occurrence of 
a 2OV  plateau (Duncan et al., 1997; Katch et al., 1982; Midgley et al., 2006). 
‘Traditional’ secondary criteria include the attainment of arbitrary thresholds for 
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maximal values of the respiratory exchange ratio and heart rate during the max2OV  
test, and early post-test blood lactate concentration (Midgley et al., 2007). Poole et al. 
(2007) recently examined the validity of secondary criteria based upon widely 
adopted threshold values for the respiratory exchange ratio, heart rate and blood 
lactate concentration in eight, apparently healthy male subjects performing a ramp-
incremented cycle ergometry test (20 W/min) to the limit of tolerance. The main 
finding of this investigation was that the secondary criteria could be satisfied at a 
2OV  much lower that the subject’s eventual maximal 2OV  attained in the test (even 
as low as 73% max2OV ). These criteria are therefore severely limited due to their 
lack of specificity in identifying subjects who have not exercised to their limit of 
tolerance (see Figure 2 for a graphical example). Conversely, as a result of 
considerable between-subject variation in maximal physiological responses, some 
subjects may not satisfy a particular criterion even when a maximum effort is given. 
This is particularly problematic for the heart rate criterion based on the attainment of a 
percentage of the age-predicted maximal heart rate, since the scatter around the 
predicted maximal heart rate for any given age introduces unacceptably large 
prediction errors (Londeree, 1984). The above observations provide a clear mandate 
for rejecting currently used secondary criteria as a means of validating a true max2OV . 
VERIFICATION PHASE 
Historical perspective 
The origin of the verification phase is presently unclear, but dates back at least to a 
book chapter by Thoden et al. (1982) published in the physiological testing guidelines 
of the Canadian Association of Sports Sciences. The authors originally termed the 
procedure the “exhaustive phase” (Thoden et al., 1982), and then later adopted the 
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terminology “verification phase” (Thoden, 1991). Thoden et al. (1982) recommended 
that after 15 min of recovery from the incremental phase, a constant bout of exercise, 
with a workload equivalent to the last completed stage in the incremental phase, 
should be performed to the limits of tolerance. If the verification phase lasted more 
than 6 min, they recommended that upon retesting, the participant be required to 
undertake a verification phase at one stage higher than the last completed stage in the 
incremental phase. In updated guidelines, Thoden (1991) suggested a recovery of 
between 5-15 min in order to obtain a heart rate of 100 beats∙min-1, with the 
verification phase initially performed at a workload one stage higher than the last 
completed stage in the incremental phase. If the incremental phase did not last at least 
8 min, the verification phase should be performed at the same workload as the last 
completed stage attained in the incremental phase of the test. Other notable 
modifications were more comprehensive guidelines regarding the intensity of the 
verification phase if a subject was retested at a later date. Subjects completing more 
than 6 min in the verification phase should perform the verification at one stage 
higher than the last completed stage in the incremental phase, regardless of the 
duration in any subsequent test. Subjects not completing a 3 min verification phase 
should undertake a verification phase at one stage lower than the last completed stage 
in the incremental phase. To the best of our knowledge, however, experiments to test 
the validity of these verification phase procedures were not conducted. 
The earliest scientific study we have found that incorporated a verification phase was 
that of Morgan et al. (1989). In that study, the verification procedure consisted of 10 
min recovery after the incremental phase, followed by a 2-min warm-up period and 2 
min of supramaximal running. The supramaximal component was performed at one 
increment higher than the last completed stage in the incremental phase. Two 
 12 
distinguishable features of the procedure used by Morgan et al. (1989) are that the 
verification phase was not continued to the subject’s limit of tolerance and was only 
performed when a 2OV  plateau was not discernable in the incremental phase. The 
efficacy of the 2-min supramaximal run for eliciting max2OV  may be questioned, 
particularly in untrained participants with slow 2OV  on-kinetics (Caputo et al., 2003). 
However, subsequent research has supported the premise that generally, 2 min of 
supramaximal exercise can be sufficient to elicit max2OV  (Rossiter et al., 2006). 
Whether the verification phase should be performed when a 2OV  plateau in the 
incremental phase is evident is a matter for debate. Not performing the verification 
phase is time efficient and does not place the subject under additional unnecessary 
stress; however, it could be argued that the verification phase provides further 
confirmation and a higher level of confidence that max2OV  was elicited. 
The verification phase has been used in subsequent experimental research, although it 
is certainly not a common procedure. In a survey of experimental studies published in 
four journals between August 2005 and July 2006, only one of 207 studies that 
determined max2OV  used the verification phase procedure (Midgley et al., 2007). 
This may be explained by a lack of research supporting its validity. Although the 
verification phase was first defined over 25 years ago, it was not until 2006 that the 
issue of whether the verification phase is a valid procedure for confirming a true 
max2OV  was specifically examined (see Table 1 for a summary of relevant studies). 
Midgley et al. (2006) reported the utility of the verification phase for determination of 
a true max2OV  in 16 male distance runners undergoing repeat speed-incremented 
treadmill tests. The verification phase was performed at a speed equivalent to one 
stage higher than that attained during the last completed stage of the incremental 
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phase. Figure 3 shows a Bland-Altman plot of the maximal 2OV  values (30-s time-
averages) attained in the incremental and verification phases for all 32 tests. The 
repeated measures coefficient of variation of 3.9%  for the maximal 2OV  during the 
verification phase was similar to the 3.5% obtained for the incremental phase, thereby 
demonstrating acceptable reproducibility. Amongst the 32 maximal tests, 26 satisfied 
a strict max2OV  verification criterion threshold of a 2OV
  not greater than 2% higher 
than the incremental phase. The 2% verification threshold was based on the technical 
error of measurement in 2OV  determination reported by the manufacturer of the 
metabolic cart used to determine pulmonary 2OV . However, this rather conservative 
criterion threshold warrants further consideration since it does not take into account 
acceptable short-term, within-subject biological variation in max2OV . 
In the same year, Rossiter et al. (2006) reported the utility of the verification phase to 
verify the max2OV  of seven apparently healthy men. In that study, participants 
performed a ramp-incremented cycle ergometer protocol (20 W/min) to the limit of 
tolerance (defined as the subject being unable to maintain a pedal cadence of at least 
50 rpm, despite strong verbal encouragement). The verification phase was performed 
after 5 min of active recovery at 20 W and consisted of cycling at 105% of the peak 
power output achieved in the ramp protocol. The authors concluded that the lack of 
significant difference between the maximal 2OV  values established at different peak 
power outputs in the two test phases satisfy the primary criterion for max2OV , even 
though the individual test phases themselves did not exhibit a plateau. On a separate 
occasion, five of the subjects replicated the procedure, except the verification phase 
was performed at 95% peak power output. The authors suggested that both 
verification phase intensities appeared equally effective at verifying that max2OV  was 
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elicited during the incremental phase. However, only the supramaximal verification 
phase can be recommended since the submaximal verification phase does not conform 
to the original concept of max2OV : that 2OV  has not increased (or at least much less 
than expected) in response to an increased workload (Hill and Lupton, 1923). 
Midgley et al. (2007) used a supramaximal verification phase to confirm that three 
different treadmill test protocols elicited true max2OV . One continuous and two 
discontinuous incremental phases, with mean times to exhaustion ranging from 10 to 
30 min, were performed. Despite the incremental phases being distinctly different, the 
mean maximal 2OV  values attained in the appended verification phases were almost 
identical. This study helps establish that in contrast to the currently used max2OV  
criteria, the verification phase is independent of the incremental test protocol. 
Foster et al (2007) recently reported the utility of the verification phase for confirming 
the max2OV  of physically active non-athletes during cycling ergometry and 
competitive runners during treadmill running. A notable characteristic of the max2OV  
test procedure was the short recovery phases of 1-min for the non-athletes and 3-min 
for the runners, compared to previous studies that used between 5 and 10 min 
(Midgley et al., 2007; Midgley et al., 2006; Rossiter et al., 2006). The negligible 
differences between the mean maximal 2OV  values attained in the incremental and 
verification phases indicated that short recovery phase durations do not detract from 
the utility of the verification procedure. A short recovery phase would be desirable 
since it is time-efficient. However, the effect of recovery phase duration and whether 
recovery is passive or active should be investigated. In relation to this, subject 
comfort should be an important consideration. 
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Two other studies incorporated the verification phase on a subsequent day to the 
incremental phase (Day et al., 2003; Hawkins et al., 2007). Day et al. (2003) used an 
average exercise intensity of 90% peak power output, whereas a recent study by 
Hawkins et al. (2007) used a power output equivalent to at least 130% max2OV . 
Although it has been reported that max2OV  can be elicited by constant load power 
outputs equivalent to 95-136% max2OV  (Hill et al., 2002), workloads equivalent to 
90% max2OV  have been shown to elicit maximal 2OV  values significantly lower 
than those attained in the incremental running test (Billat et al., 1995). However, the 
identical mean maximal 2OV  values in the incremental and verification phases 
reported by Day et al. (2003), does support the view that a constant load bout of 
exercise at 90% peak power output did indeed elicit max2OV . Possible explanations 
for this discrepancy might be differences in the exercise modality or the fitness of the 
subjects that were used, or differences in the incremental test protocols that meant that 
the subjects in these two studies could have been exercising at different relative 
intensities. This latter point is based on the observation that peak work rate and the 
work rate- 2OV  relationship attained in an incremental test is somewhat dependent on 
the characteristics of the test protocol (Bentley and McNaughton, 2003). Performing 
the verification phase on a separate day is advantageous in that the subject is likely to 
be less fatigued, which may result in an increased time to exhaustion and increased 
likelihood that a maximal 2OV  is elicited. However, there appears to be no reduction 
in the discrepancies between the mean maximal 2OV  attained in the incremental and 
verification phases (Table 1). Furthermore, although the verification phase may be 
better tolerated if performed on a separate day, the additional visit to the laboratory 
considerably reduces the utility of this approach. 
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Directions for future research 
Five of the six studies that have investigated the utility of the verification phase have 
compared the mean differences between the maximal 2OV  values attained in the 
incremental and verification phases (Day et al., 2003; Foster et al., 2007; Hawkins et 
al., 2007; Poole et al., 2007; Rossiter et al., 2006). Noakes (2008) recently criticised 
this approach, stating that exercise testing is performed on individuals not groups, and 
therefore, the group mean approach does not identify subjects who might not have 
elicited a true max2OV . It is also noteworthy that the original description of the 
verification phase procedure by Thoden et al. (1991; 1982) did not include a criterion 
threshold for making a decision of whether an individual has attained a true max2OV . 
Future research should attempt to establish the most appropriate verification criterion 
threshold to verify a true max2OV . 
The same-day verification phase has consisted of a single square wave exercise bout 
with no preceding warm-up period (Foster et al., 2007; Midgley et al., 2006; Rossiter 
et al., 2006). For individuals with slow 2OV  on-kinetics, such as the untrained 
(Hickson et al., 1978) and individuals with certain pathological conditions (Nery et al., 
1982; Sietsema et al., 1986), this approach may not allow sufficient time for 2OV  to 
reach its maximum before reaching their limit of tolerance. Performing the 
verification phase at a very high intensity, such as the ≥130% max2OV  used by 
Hawkins et al. (2007), may exacerbate this problem. A square wave transition from 
rest to supramaximal exercise also may be poorly tolerated. In contrast, subjects are 
likely to reach their limit of exercise tolerance before max2OV  is attained in square 
wave exercise bouts that are below the severe exercise domain (i.e. below the work 
rate associated with the maximal lactate steady state; Poole et al., 1988). Alternative 
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approaches could be a multi-stage verification phase that incorporates lower intensity 
exercise immediately before the supramaximal effort, or a brief warm-up and a short 
incremental verification phase, for example, starting at three stages below the last 
completed stage in the prior incremental phase. Regardless of the protocol, the 
verification phase should incorporate a workload higher than that attained in the 
incremental phase to conform to the original concept of max2OV  (Hill and Lupton, 
1923). 
Myers et al (1990) reported that the choice of 2OV  sampling interval can have a 
profound effect on the 2OV  value obtained. These authors reported that small 
sampling intervals (e.g. 5-10 s) result in unacceptable variability, whereas intervals 
that are too large (e.g. 60 s) may be too imprecise for accurately determining rapidly 
changing 2OV  responses (as in a max2OV  test). The effect of the 2OV  data 
sampling method on the difference between the maximal 2OV  values attained in the 
incremental and verification phases has not been investigated. Researchers have thus 
far used 15-s (Rossiter et al., 2006), 20-s (Poole et al., 2007), or 30-s (Foster et al., 
2007; Midgley et al., 2007; Midgley et al., 2006) time averages, or continuous 45-s 
Douglas bag sampling (Hawkins et al., 2007). Since the verification phase can be less 
than 2 min (Midgley et al., 2006; Rossiter et al., 2006), a shorter time interval may be 
preferable, although this may not sufficiently smooth the considerable noise inherent 
to 2OV  data (Lamarra et al., 1987). Further research is required to investigate an 
optimal 2OV  smoothing method that has high precision for rapidly changing 2OV , 
whilst limiting variability around the underlying trend. 
Midgley et al. (2006) suggested that maximal heart rate values for the incremental and 
verification phases that agree within 2 beats∙min-1 of each other, would provide a high 
 18 
degree of confidence that a subject has given a maximal effort in the incremental 
phase. Maximal heart rate verification could replace the current heart rate criterion 
based on attainment of a percentage of age-predicted maximal heart rate (Howley et 
al., 1995). Maximal heart verification is advantageous because it is not affected by the 
large imprecision associated with age-predicted maximal heart rate (Londeree, 1984). 
The small systematic bias towards a lower maximal heart rate in the verification phase 
reported by Midgley et al. (2006), however, suggests that the verification procedure 
requires modification before maximal heart rate verification can be recommended as a 
valid max2OV  criterion. The authors concluded that the verification phase may have 
been too short for some subjects to attain their maximal heart rate and that a multi-
stage verification phase incorporating lower intensity exercise may negate this 
problem. 
A potential limitation of the verification phase is that subjects are required to exercise 
to the limit of their tolerance twice within the same testing session. The original 
recommendations made by Thoden et al. (1991; 1982) were physiological testing 
guidelines for elite athletes. Current research suggests that the verification phase is 
well tolerated in athletic as well as apparently healthy sedentary populations. 
However, future research should establish whether this procedure is sufficiently 
tolerated by other populations such as children, the elderly, the obese, and individuals 
with particular chronic diseases. For some of these individuals it may be considered 
unethical to ask them to exercise to their limit of tolerance twice in the same testing 
session. Moreover, individuals with low exercise tolerance may be unwilling or 
unable to perform the verification phase. 
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PERSPECTIVES 
The max2OV  test is a widely used procedure and robust methodology for the 
determination of max2OV  is important for experimental research where invalid 
max2OV  values could alter the outcome of the research findings. The currently used 
criteria for confirming a true max2OV  have been strongly criticised in relation to their 
lack of validity, mainly because they are unduly influenced by the max2OV  test 
duration, exercise modality, and between-subject differences in maximal attainable 
physiological values. Further research is therefore needed to identify new criteria that 
are not influenced by these factors. One procedure that appears to yield such criteria is 
the verification phase; however, there has so far been relatively little research 
investigating the utility of this procedure. This review presents the current state of 
knowledge regarding the verification phase procedure, with a view that it provides a 
platform for future research into max2OV  criteria derived from the verification phase.
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Table 1. Mean (SD) maximal 2OV
  values attained in the incremental and verification phases of max2OV
  tests conducted during previous studies. All mean differences 
between incremental and verification phases, for all studies,  were not statistically significant. 
Reference Incremental phase 
 
Recovery 
phase 
Verification phase
 
Verification  in 
same testing 
session? 
Maximal 
incremental phase  
2OV
  (mL·min-1 )
 
Maximal 
verification phase  
2OV
  (mL·min-1 )
 
Day et al. 
(2003) 
Ramp incremented cycle ergometer 
test. 
not 
applicable 
90% of peak power output attained in the 
incremental phase. 
separate day 3640 (700) 3640 (700) 
Midgley et al. 
(2006) 
Continuous treadmill test. 1 min stages. 10 min 
active 
0.5 km·h-1 higher than the last completed 
stage in the incremental phase. 
yes 4041 (455) 3994 (447) 
 Repeat trial of above. 10 min 
active 
Repeat trial of above. yes 4010 (379) 4029 (432) 
Rossiter et al. 
(2006) 
Ramp incremented cycle ergometer 
test. 
5 min 
active 
95% of peak power output attained in the 
incremental phase. 
yes 4105 (478) 4117 (528) 
 Ramp incremented cycle ergometer 
test. 
5 min 
active 
105% of peak power output attained in the 
incremental phase. 
yes 4149 (502) 4090 (446) 
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Table 1. Continued. 
Reference Incremental phase 
 
Recovery 
phase 
Verification phase
 
Verification  in 
same testing 
session? 
Maximal 
incremental phase  
2OV
  (mL·min-1 )
 
Maximal 
verification phase  
2OV
  (mL·min-1 )
 
Midgley et al. 
(2007) 
Continuous treadmill test. 1 min stage 
durations. 
5 min 
passive 
0.5 km·h-1 higher than the last completed 
stage in the incremental phase. 
yes 4093 (538) 4068 (531) 
 Discontinuous treadmill test. 2 min 
stages, with 30-s rest between stages. 
5 min 
passive 
1 km·h-1 higher than the last completed 
stage in the incremental phase. 
yes 4096 (516) 4075 (522) 
 Discontinuous treadmill test. 3 min 
stages, 30-s rest between stages. 
5 min 
passive 
1 km·h-1 higher than the last completed 
stage in the incremental phase. 
yes 3980 (488) 4071 (531) 
Hawkins et al. 
(2007) 
Continuous treadmill test. 2 minute 
stages. 
not 
applicable 
Work load equivalent to that requiring 
≥130% max2OV
 . 
separate day 63.3 (6.3)† 62.9 (6.2)† 
Foster et al. 
(2007) 
Continuous cycle ergometer test. 1 min 
stage durations. 
1 min 
active 
25 W higher than that attained in the last 
stage of the incremental phase. 
yes 3950 (750) 4060 (750) 
 Continuous treadmill test. 3 min stage 
durations. 
3 min 
active 
0.8 km·h-1 (females) and 1.6 km·h-1 
(males) higher than that attained in the 
last stage of the incremental phase. 
yes 4090 (970) 4030 (1160) 
Poole et al. 
(2008) 
Ramp incremented cycle ergometer 
test. 
not 
applicable 
105% of peak power output attained in the 
incremental phase. 
separate day 4030 (100) 3950 (110) 
† Reported in mL∙kg-1∙min-1. Values in mL·min-1 or body mass of subjects not reported in original study 
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FIGURE 1. The 2OV
  response of one male subject to a continuous, step-
incremented (30 W·min-1) cycle ergometer test, incorporating subsequent 
recovery and verification phases. The verification phase consisted of cycling 
at 50% peak power output (defined as the power output associated with the 
last completed stage of the incremental phase) for 2 min, at 70% peak power 
output for 1 min, and then at one stage higher than peak power output to the 
limit of exercise tolerance. Note that although there was no clearly discernable 
2OV
  plateau in the incremental phase, there was only a 0.8% difference 
between the maximal 2OV
  attained in the incremental phase (3677 mL·min-1) 
and that attained in the verification phase (3648 mL·min-1). 
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FIGURE 2. The 2OV
  and respiratory exchange ratio of a club-level cyclist 
during an incremental max2OV
  test. Note that the cyclist would have satisfied 
an RER criterion of 1.10 at a 2OV
  of 3915 mL∙min-1 (90% max2OV
 ). The grey 
area represents the part of the test that would have been omitted if the subject 
had terminated the test at a respiratory exchange ratio of 1.10. 
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FIGURE 3. Bland-Altman plot showing individual differences between the 
maximal 2OV
  values attained in the incremental and verification phases of a 
max2OV
  test plotted against their individual mean values (Midgley et al., 2006). 
The horizontal dashed lines represent the mean difference and 95% limits of 
agreement. Sd = standard deviation of the differences. 
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